Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/32111
Title: A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder.
Authors: 
Mesh: 
Issue Date: Jun-2017
Citation: J Clin Psychopharmacol.2017 Jun;(37)3:315-322
Abstract: A 12-month, open-label extension study assessed the long-term safety and tolerability of lisdexamfetamine dimesylate (LDX) in adults with binge eating disorder (BED).
PMID: 28383364
URI: https://hdl.handle.net/20.500.12530/32111
Rights: openAccess
Appears in Collections:Hospitales > H. U. Infanta Leonor > Artículos

Files in This Item:
File Description SizeFormat 
PMC5400413.pdf323.65 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.